ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0817

Comparative Effectiveness of Yoga and Strengthening Exercise for Treating Knee OsteoArthritis: A Randomised Controlled Trial (YOGA Trial)

Bedru Abafita1, Ambrish Singh1, Dawn Aitken1, Steffany Moonaz2, Andrew J Palmer1, Leigh Blizzard1, Changhai Ding1, Stan Drummen1, Graeme Jones3, Kim Bennell4 and Benny Samuel Antony1, 1Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia, 2Department of Clinical and Health Services Research, Southern California University of Health Sciences, Whittier, CA, 3Menzies Institute for Medical Research, University of Tasmania, Melbourne, Australia, 4University of Melbourne, Melbourne, Australia

Meeting: ACR Convergence 2023

Keywords: clinical trial, comparative effectiveness, exercise, Osteoarthritis, pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: Abstracts: Osteoarthritis I: Clinical Trials

Session Type: Abstract Session

Session Time: 4:00PM-5:30PM

Background/Purpose: There is uncertainty about the best type of exercise to optimise outcomes for people with knee osteoarthritis (OA). Strengthening exercise is commonly recommended. However, yoga may have greater effects than strengthening given its focus on the mind and body with purposed benefits on flexibility, muscle strength, balance, fitness, while addressing the psychosocial sequelae. This study compared the effectiveness of a 24-week yoga program to strengthening exercise for knee OA.

Methods: The YOGA trial is an assessor-blinded (for non-patient-reported outcomes) randomised, active controlled superiority trial that included pre-specified non-inferiority outcomes. We recruited eligible symptomatic knee OA participants aged ≥40 years who fulfilled ACR clinical criteria with knee pain ≥40mm on 100mm visual analog scale (VAS). Participants were randomly assigned to a 24-week yoga program or strengthening exercise program (two supervised sessions and one home-based session per week for 12 weeks + three home-based sessions per week from 13-24 weeks). The primary outcome was change in knee pain over 12 weeks, assessed on a 100mm VAS. Secondary outcomes included, WOMAC scores, patient global assessment, physical performance measures, quality of life, depression, and neuropathic pain over 12 and 24 weeks.

Results: We screened 213 participants for eligibility between June 2021 and June 2022 and randomly assigned 117 participants to a yoga program (n=58) or a strengthening exercise program (n=59). Baseline characteristics of the participants between the groups were similar, with a mean (SD) age of 62.5(8.3) years, and 72.6% were female. Over 12 weeks, VAS knee pain score did not differ significantly between yoga and strengthening exercise groups with a between-group difference of -1.1mm [95%CI:-7.8,5.7]. Similarly, the VAS knee pain over 24 weeks was not significantly different (-5.8 mm [95%CI:-12.8,1.2]). The yoga group showed significantly greater improvements than the strengthening exercise group over 24 weeks (between-group difference) for WOMAC pain (-44.5mm [95%CI:-70.7,-18.3]), WOMAC function (-139mm [95%CI:-228.3,–49.7]), WOMAC stiffness (-17.6mm [95%CI:-30.9,-4.3]) and patient global assessment (-7.6mm [95%CI:-15.1,-0.2]). Additionally, yoga group had a significantly greater improvement than the strengthening exercise in depression (-1.1 [95%CI:-1.9,-0.2]) over 12 weeks and quality of life (0.04 unit [95%CI:0.0,0.07]) over 24 weeks. No serious adverse events were reported. There were 31 non-serious adverse events in 22(39%) participants in the yoga group and 23 in 16 (28%) participants in the strengthening exercise group over 24 weeks, mostly not related to the interventions.

Conclusion: A 24-week yoga program did not significantly reduce knee pain more than a strengthening exercise program over 12 weeks in participants with knee OA. However, the yoga program was non-inferior to strengthening exercise, as per the pre-determined non-inferiority margin. Secondary outcomes indicated that the yoga program resulted in modestly greater improvements in knee symptoms, depression, and quality of life over 24 weeks compared to strengthening exercise.

Supporting image 1

Figure 1. Mean visual analog scale (VAS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) subscale scores (95%CI) in the yoga and strengthening exercise groups during 24 weeks of intervention.


Disclosures: B. Abafita: None; A. Singh: None; D. Aitken: None; S. Moonaz: None; A. Palmer: None; L. Blizzard: None; C. Ding: None; S. Drummen: None; G. Jones: None; K. Bennell: None; B. Antony: None.

To cite this abstract in AMA style:

Abafita B, Singh A, Aitken D, Moonaz S, Palmer A, Blizzard L, Ding C, Drummen S, Jones G, Bennell K, Antony B. Comparative Effectiveness of Yoga and Strengthening Exercise for Treating Knee OsteoArthritis: A Randomised Controlled Trial (YOGA Trial) [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/comparative-effectiveness-of-yoga-and-strengthening-exercise-for-treating-knee-osteoarthritis-a-randomised-controlled-trial-yoga-trial/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparative-effectiveness-of-yoga-and-strengthening-exercise-for-treating-knee-osteoarthritis-a-randomised-controlled-trial-yoga-trial/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology